A
A 26-year-old graduate has died from a rare complication of the AstraZenecaCovid vaccine after receiving out-of-date information about the risk of blood clots, according to an investigation.
Jack Hurn, originally from Devon but living in Redditch, Worcestershire, died in June last year, less than two weeks after being hit in the West Midlands.
A one-week investigation in Birmingham Forensic Court was told that a GP informed Mr. Hurn said the risk of blood clots in the brain for his age group was one in 250,000, when the latest NHS guide estimated it to be one in 50,000.
The survey found that Coventry University’s graduate in automotive design chose to go ahead with his first dose of the AstraZeneca vaccine on May 29, 2021, after being told that the vaccination center of Revival Fairs in Dudley had no stock of the Pfizer vaccine.
Hurn, whose girlfriend Alex Jones also received the AstraZeneca vaccine at the clinic, felt unwell eight days after the blow and died at the hospital on June 11 despite emergency surgery.
READ MORE
Jack Hurn dies due to rare complication of AstraZeneca Covid vaccine after receiving obsolete information (Family Brochure / FCB Manby Bowdler / PA)
The NHS’s orientation at the time was to offer patients under the age of 40 an alternative to the AstraZeneca vaccine, although they could decide “an informed choice” to receive it.
Recording a narrative verdict on Friday, Birmingham coroner Emma Brown said: “She agrees that Jack was told the risk was one in 250,000.
“It simply came to our notice then.
“At the time, the Joint Committee on Vaccines and Immunization had advised that it would be preferable for adults under the age of 40 without underlying conditions to be offered an alternative to the AstraZeneca Covid-19 vaccine.
“But people could make an informed decision to get the AstraZeneca vaccine for earlier protection.
Jack with his partner Alex. (Family Brochure / FCB Manby Bowdler / PA)
Ms Brown added: “Jack did not receive all the information to make an informed choice.
“In particular, the risk of complications for their age group was underestimated.”